Signal
15 articles covering "acquisition"
OpenAI said on November 4 it will acquire Pierre Computer, maker of Code Storage and the Trees and Diffs libraries used in Codex; terms were not disclosed and closing needs regulatory approvals.
EDB announced the acquisition of Altinity on November 5, 2026; terms were not disclosed, integrated ClickHouse offerings are planned for Q4 2026, and two analysts quoted by TechTarget say integration work remains.
Deno's team is joining Cloudflare; Deno says it will support the runtime for one more year, run Deno Deploy for six months, and merge celld into workerd.
ClickHouse acquired security data platform RunReveal, folding in-house the expertise behind a product already built on its own database.
AMD is buying Toronto-based Taalas, whose chips etch model weights directly into silicon instead of storing them in memory, to strengthen its AI inference lineup.
Rocket Lab agreed to buy satellite operator Iridium for $54 a share, an $8 billion deal that would let it build, launch, and operate its own constellations.
Reports say Qualcomm is examining a full acquisition of Tenstorrent, the RISC-V AI accelerator startup led by Jim Keller, at a valuation between $8 billion and $10 billion.
Qualcomm agreed to acquire Modular in an all-stock deal worth about $3.9 billion, expected to close in the second half of 2026.
EA cut an undisclosed number of jobs in customer support, IT, recruitment, and trust and safety across US remote roles and its Hyderabad office, its third layoff round of 2026 as the PIF-led buyout closes in.
EA shareholders approved the $55B PIF-led acquisition in late December; Canadian union CWA Canada has urged Ottawa to review the deal under the Investment Canada Act.
Locus Robotics buys Vancouver-based Nexera Robotics, adding NeuraGrasp's patented soft-membrane gripper to its Locus Array autonomous fulfillment system.
Eli Lilly acquired Engage Bio and its Tethosome non-viral DNA delivery platform for up to $202 million, aiming to overcome the immune and redosing limits of viral gene therapies.